-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Financial Contrast: Central Puerto (NYSE:CEPU) and Biotricity (OTCMKTS:BTCY)
Financial Contrast: Central Puerto (NYSE:CEPU) and Biotricity (OTCMKTS:BTCY)
Central Puerto (NYSE:CEPU – Get Rating) and Biotricity (OTCMKTS:BTCY – Get Rating) are both small-cap oils/energy companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, valuation, earnings, institutional ownership and profitability.
Profitability
This table compares Central Puerto and Biotricity's net margins, return on equity and return on assets.
Get Central Puerto alerts:Net Margins | Return on Equity | Return on Assets | |
Central Puerto | 16.67% | 7.33% | 4.68% |
Biotricity | N/A | N/A | N/A |
Analyst Ratings
This is a summary of recent ratings for Central Puerto and Biotricity, as reported by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Central Puerto | 0 | 0 | 0 | 0 | N/A |
Biotricity | 0 | 1 | 2 | 0 | 2.67 |
Earnings & Valuation
This table compares Central Puerto and Biotricity's gross revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Central Puerto | $600.19 million | 1.07 | -$7.79 million | $0.66 | 6.45 |
Biotricity | $7.70 million | 6.25 | -$32.70 million | ($0.63) | -1.47 |
Central Puerto has higher revenue and earnings than Biotricity. Biotricity is trading at a lower price-to-earnings ratio than Central Puerto, indicating that it is currently the more affordable of the two stocks.
Institutional and Insider Ownership
2.6% of Central Puerto shares are owned by institutional investors. Comparatively, 5.1% of Biotricity shares are owned by institutional investors. 0.1% of Central Puerto shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Risk & Volatility
Central Puerto has a beta of 1.42, meaning that its share price is 42% more volatile than the S&P 500. Comparatively, Biotricity has a beta of 1.69, meaning that its share price is 69% more volatile than the S&P 500.
Summary
Central Puerto beats Biotricity on 8 of the 13 factors compared between the two stocks.
About Central Puerto
(Get Rating)
Central Puerto S.A. generates and sells electric power to private and public customers in Argentina. It also produces steam. As of December 31, 2021, the company owned and operated five thermal generation plants, one hydroelectric generation plant, and seven wind farms with a total installed capacity of 4,809 MW. Central Puerto S.A. was founded in 1898 and is based in Buenos Aires, Argentina.
About Biotricity
(Get Rating)
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.
Receive News & Ratings for Central Puerto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Central Puerto and related companies with MarketBeat.com's FREE daily email newsletter.
Central Puerto (NYSE:CEPU – Get Rating) and Biotricity (OTCMKTS:BTCY – Get Rating) are both small-cap oils/energy companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, valuation, earnings, institutional ownership and profitability.
波多黎各中部(纽约证券交易所代码:CEPU — 获取评级)和Biotricity(OTCMKTS: BTCY — 获取评级)都是小型石油/能源公司,但哪种投资更好?我们将根据两家公司的分析师建议、风险、股息、估值、收益、机构所有权和盈利能力对两家公司进行比较。
Profitability
盈利能力
This table compares Central Puerto and Biotricity's net margins, return on equity and return on assets.
该表比较了中央波多黎各和Biotricity的净利润率、股本回报率和资产回报率。
Net Margins | Return on Equity | Return on Assets | |
Central Puerto | 16.67% | 7.33% | 4.68% |
Biotricity | N/A | N/A | N/A |
净利润 | 股本回报率 | 资产回报率 | |
中波多黎各 | 16.67% | 7.33% | 4.68% |
Biotricity | 不适用 | 不适用 | 不适用 |
Analyst Ratings
分析师评级
This is a summary of recent ratings for Central Puerto and Biotricity, as reported by MarketBeat.com.
据Marketbeat.com报道,这是波多黎各中心和Biotricity最近评级的摘要。
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Central Puerto | 0 | 0 | 0 | 0 | N/A |
Biotricity | 0 | 1 | 2 | 0 | 2.67 |
卖出评级 | 保持收视率 | 买入评级 | 强劲的买入评级 | 评分分数 | |
中波多黎各 | 0 | 0 | 0 | 0 | 不适用 |
Biotricity | 0 | 1 | 2 | 0 | 2.67 |
Earnings & Valuation
收益与估值
This table compares Central Puerto and Biotricity's gross revenue, earnings per share and valuation.
该表比较了中央波多黎各和Biotricity的总收入、每股收益和估值。
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Central Puerto | $600.19 million | 1.07 | -$7.79 million | $0.66 | 6.45 |
Biotricity | $7.70 million | 6.25 | -$32.70 million | ($0.63) | -1.47 |
总收入 | 价格/销售比率 | 净收入 | 每股收益 | 市盈率 | |
中波多黎各 | 60.019 亿美元 | 1.07 | -779 万美元 | 0.66 美元 | 6.45 |
Biotricity | 770 万美元 | 6.25 | -3270 万美元 | (0.63 美元) | -1.47 |
Central Puerto has higher revenue and earnings than Biotricity. Biotricity is trading at a lower price-to-earnings ratio than Central Puerto, indicating that it is currently the more affordable of the two stocks.
波多黎各中部的收入和收益高于Biotricity。Biotricity的市盈率低于中央波多黎各,这表明它目前是这两只股票中更实惠的一只。
Institutional and Insider Ownership
机构所有权和内部所有权
2.6% of Central Puerto shares are owned by institutional investors. Comparatively, 5.1% of Biotricity shares are owned by institutional investors. 0.1% of Central Puerto shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
波多黎各中部2.6%的股票由机构投资者持有。相比之下,Biotricity的5.1%股票由机构投资者持有。0.1%的中央波多黎各股票由内部人士持有。强大的机构所有权表明,捐赠基金、大型基金经理和对冲基金认为一家公司已为长期增长做好了准备。
Risk & Volatility
风险与波动性
Central Puerto has a beta of 1.42, meaning that its share price is 42% more volatile than the S&P 500. Comparatively, Biotricity has a beta of 1.69, meaning that its share price is 69% more volatile than the S&P 500.
波多黎各中部的beta值为1.42,这意味着其股价的波动性比标准普尔500指数高42%。相比之下,Biotricity的beta值为1.69,这意味着其股价的波动性比标准普尔500指数高69%。
Summary
摘要
Central Puerto beats Biotricity on 8 of the 13 factors compared between the two stocks.
与两只股票相比,波多黎各中部在13个因素中的8个方面击败了Biotricity。
About Central Puerto
关于波多黎各中部
(Get Rating)
(获取评分)
Central Puerto S.A. generates and sells electric power to private and public customers in Argentina. It also produces steam. As of December 31, 2021, the company owned and operated five thermal generation plants, one hydroelectric generation plant, and seven wind farms with a total installed capacity of 4,809 MW. Central Puerto S.A. was founded in 1898 and is based in Buenos Aires, Argentina.
Central Puerto S.A. 发电并向阿根廷的私人和公共客户出售电力。它还会产生蒸汽。截至 2021 年 12 月 31 日,该公司拥有并运营五座火力发电厂、一座水力发电厂和七个风力发电场,总装机容量为 4,809 兆瓦。Central Puerto S.A. 成立于 1898 年,总部位于阿根廷布宜诺斯艾利斯。
About Biotricity
关于 Biotricity
(Get Rating)
(获取评分)
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.
Biotricity, Inc. 是一家医疗技术公司,主要在美国提供生物识别数据监控解决方案。该公司专注于为医疗、医疗保健和消费市场提供远程监控解决方案,包括针对生活方式和慢性病的诊断和后诊断解决方案。它提供Bioflux移动心脏遥测解决方案,一种集成的心电图设备;以及用于分析和合成患者心电图监测数据的心电图分析软件以及软件组件。该公司总部位于加利福尼亚州雷德伍德城。
Receive News & Ratings for Central Puerto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Central Puerto and related companies with MarketBeat.com's FREE daily email newsletter.
接收波多黎各中央日报的新闻和评级 -在下面输入您的电子邮件地址,即可通过Marketbeat.com的免费每日电子邮件时事通讯接收波多黎各中央及相关公司的最新新闻和分析师评级的简要每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧